Pakistani scientists have made significant breakthroughs with the new novel Coronavirus, identifying possible drugs to treat it.
In this study by Dr. Panjuani Center for Molecular Medicine and Drug Research at Karachi University, 3 drugs and 2 natural compounds approved by the US Food and Drug Administration (FDA) for the treatment of coronavirus are important for its treatment. Declared
The study, published in the Journal of Biomolecular Structure and Dynamics, states that there is currently no approved treatment for the new novel coronavirus disease and that computational approaches to FDA-approved antiviral drugs Tried by
The researchers identified three FDA-approved drugs, Remedicavir, Saquinavir, and Darnovir, as well as two natural compounds, Flavon and Quiomarine Drusteus, as important in treating Covid 19.
Saquinavir and Darnovir are drugs sold under different names that are used to treat and prevent HIV / AIDS but are also recommended for other viruses.
Flavon is a natural compound that is red. In addition to purple fruits and vegetables, it is found in various plant species, while the other compound is commonly used to prevent vitamin problems.
The study analyzed 16 FDA-approved drugs and several natural compounds.
The researchers looked at how these drugs affect the structure of the new novel coronavirus and target proteins that target cells.
They discovered that the above drugs and 2 natural molecules target the process of infecting the virus cells or making their own copies.
It should be noted that this study was not conducted on patients but the researchers stressed that more work should be done in this regard which could help in the identification and preparation of a new novel coronavirus treatment on a rapid basis.
The research team included Salman Ali Khan, Komal Zia, Sajida Ashraf, Riaz-ud-Din, and Zaheer-ul-Haq.
The study was submitted to the journal on March 1 and accepted on April 30, after which it was published in mid-April.
It should be noted that the remediator has already been approved in the United States to be used for the treatment of people undergoing treatment in the hospital after contracting the new novel coronavirus.